Monoclonal antibody (mAb) therapy involves making large amounts of antibodies that recognize antigens that are usually found on the surface of cancer cells. They are then injected into the body ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally ...

The SADA technology was developed at Memorial Sloan Kettering Cancer Center and is exclusively licensed to Y-mAbs. Presentation of significant preclinical and translational pharmacokinetics data ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...

Y-mAbs is highlighted as a commercial-stage biopharmaceutical company with a focus on innovative cancer treatments, showcasing its commitment to addressing unmet medical needs. The mention of ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Equities research analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Tuesday. The ...